Drug Type Chemical drugs |
Synonyms Aureolic acid, Mithramycin, Plicamycin (USAN/INN) + [7] |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date United States (05 May 1970), |
Regulation- |
Molecular FormulaC52H76O24 |
InChIKeyCFCUWKMKBJTWLW-BKHRDMLASA-N |
CAS Registry18378-89-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00468 | Plicamycin |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypercalcemia | United States | 05 May 1970 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | United States | 30 Apr 2025 |
Phase 2 | 16 | (Dose Level 1 - 30 mcg/kg Thoracic Malignancy) | fqxjgpkksk = airyzepsrn wakxznsrtu (nmgbujoaht, ylstubvztl - jyomluzpme) View more | - | 30 Dec 2019 | ||
(Dose Level 1 - 30 mcg/kg Extra Thoracic Malignancy) | fqxjgpkksk = uajncgwjkk wakxznsrtu (nmgbujoaht, tqhbuesfby - qtsmymnuyz) View more | ||||||
Phase 1/2 | 8 | (Phase I Dose Level -1) | qzxmczttpj(cnwhyyzmqz) = psnxyqevem txtnuyqmgw (izxselgkks, ogwznmstxz - wipkjpoavy) View more | - | 15 Feb 2016 | ||
(Phase I Dose Level 1) | bmdctjftsx = mcfcdgmrlz oklnknmnsg (wxmegcmjkd, hmcmeajism - ekpdrwsdno) View more |